Recruiting
Phase 2

Spironolactone with Chlorthalidone

Sponsor:

Indiana Institute for Medical Research

Code:

NCT05222191

Conditions

Renal Insufficiency

Chronic Hypertension

Eligibility Criteria

Sex: All

Age: 19 - 70+

Healthy Volunteers: Not accepted

Interventions

Spironolactone

Chlorthalidone

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-29. This information was provided to ClinicalTrials.gov by Indiana Institute for Medical Research on 2023-08-14.